APA

Xue X., Zhang Y., Wang C., Zhang M., Xiang Q., Wang J., Wang A., Li C., Zhang C., Zou L., Wang R., Wu S., Lu Y., Chen H., Ding K., Li G. & Xu Y. (20180619). Benzoxazinone-containing 3,5-dimethylisoxazole derivatives as BET bromodomain inhibitors for treatment of castration-resistant prostate cancer. : European journal of medicinal chemistry.

Chicago

Xue Xiaoqian, Zhang Yan, Wang Chao, Zhang Maofeng, Xiang Qiuping, Wang Junjian, Wang Anhui, Li Chenchang, Zhang Cheng, Zou Lingjiao, Wang Rui, Wu Shuang, Lu Yongzhi, Chen Hongwu, Ding Ke, Li Guohui and Xu Yong. 20180619. Benzoxazinone-containing 3,5-dimethylisoxazole derivatives as BET bromodomain inhibitors for treatment of castration-resistant prostate cancer. : European journal of medicinal chemistry.

Harvard

Xue X., Zhang Y., Wang C., Zhang M., Xiang Q., Wang J., Wang A., Li C., Zhang C., Zou L., Wang R., Wu S., Lu Y., Chen H., Ding K., Li G. and Xu Y. (20180619). Benzoxazinone-containing 3,5-dimethylisoxazole derivatives as BET bromodomain inhibitors for treatment of castration-resistant prostate cancer. : European journal of medicinal chemistry.

MLA

Xue Xiaoqian, Zhang Yan, Wang Chao, Zhang Maofeng, Xiang Qiuping, Wang Junjian, Wang Anhui, Li Chenchang, Zhang Cheng, Zou Lingjiao, Wang Rui, Wu Shuang, Lu Yongzhi, Chen Hongwu, Ding Ke, Li Guohui and Xu Yong. Benzoxazinone-containing 3,5-dimethylisoxazole derivatives as BET bromodomain inhibitors for treatment of castration-resistant prostate cancer. : European journal of medicinal chemistry. 20180619.